Effect of Phosphatase Activity of the Control of Virulence Sensor (CovS) on Clindamycin-Mediated Streptolysin O Production in Group A
Anti-Bacterial Agents
/ pharmacology
Bacterial Proteins
/ biosynthesis
Clindamycin
/ pharmacology
Histidine Kinase
/ antagonists & inhibitors
Magnesium
/ pharmacology
Phosphoric Monoester Hydrolases
/ metabolism
Repressor Proteins
/ metabolism
Streptococcus pyogenes
/ metabolism
Streptolysins
/ biosynthesis
CovR/CovS
NADase
SLO
clindamycin
group A Streptococcus
Journal
Infection and immunity
ISSN: 1098-5522
Titre abrégé: Infect Immun
Pays: United States
ID NLM: 0246127
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
29
07
2019
accepted:
09
09
2019
pubmed:
19
9
2019
medline:
22
1
2020
entrez:
19
9
2019
Statut:
epublish
Résumé
Severe manifestations of group A
Identifiants
pubmed: 31527126
pii: IAI.00583-19
doi: 10.1128/IAI.00583-19
pmc: PMC6867833
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Bacterial Proteins
0
CsrR protein, Streptococcus pyogenes
0
Repressor Proteins
0
Streptolysins
0
streptolysin O
0
Clindamycin
3U02EL437C
CovS protein, Streptococcus pyogenes
EC 2.7.13.1
Histidine Kinase
EC 2.7.13.1
Phosphoric Monoester Hydrolases
EC 3.1.3.2
Magnesium
I38ZP9992A
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2019 American Society for Microbiology.
Références
PLoS Pathog. 2018 Oct 31;14(10):e1007354
pubmed: 30379939
Infect Immun. 2015 Mar;83(3):1068-77
pubmed: 25561708
PLoS Pathog. 2011 Oct;7(10):e1002361
pubmed: 22046138
Infect Immun. 2009 Aug;77(8):3141-9
pubmed: 19451242
Nat Med. 2007 Aug;13(8):981-5
pubmed: 17632528
PLoS Pathog. 2006 Jan;2(1):e5
pubmed: 16446783
Mol Microbiol. 2001 May;40(4):976-90
pubmed: 11401704
Euro Surveill. 2015 May 07;20(18):null
pubmed: 25990232
J Clin Microbiol. 2009 Oct;47(10):3161-9
pubmed: 19710271
Mol Microbiol. 2002 Apr;44(1):257-69
pubmed: 11967084
J Bacteriol. 2019 Jan 28;201(4):
pubmed: 30478086
J Infect Dis. 2017 Jan 15;215(2):269-277
pubmed: 27247345
Front Microbiol. 2018 Mar 23;9:542
pubmed: 29628918
Nat Methods. 2011 Feb;8(2):104-5
pubmed: 21278720
N Engl J Med. 2017 Dec 7;377(23):2253-2265
pubmed: 29211672
J Biol Chem. 1999 Feb 19;274(8):4786-93
pubmed: 9988717
PLoS One. 2015 Sep 04;10(9):e0137313
pubmed: 26340445
Antimicrob Agents Chemother. 2010 Jan;54(1):98-102
pubmed: 19805566
Mol Microbiol. 2005 Jun;56(5):1195-207
pubmed: 15882414
Int J Med Microbiol. 2017 Sep;307(6):329-339
pubmed: 28648357
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4227-32
pubmed: 12646707
Antimicrob Agents Chemother. 2007 Feb;51(2):461-7
pubmed: 17101685
Clin Infect Dis. 2014 Aug 1;59(3):366-8
pubmed: 24785238
Infect Immun. 1999 Oct;67(10):5495-9
pubmed: 10496938
Trends Microbiol. 2003 May;11(5):224-32
pubmed: 12781526
Arch Biochem Biophys. 2011 Aug 1;512(1):1-23
pubmed: 21640700
Front Microbiol. 2017 Jun 08;8:1052
pubmed: 28642756
Clin Infect Dis. 2014 Jul 15;59(2):e10-52
pubmed: 24973422
J Infect Chemother. 2015 May;21(5):398-401
pubmed: 25618777
Med Mal Infect. 2015 Nov-Dec;45(11-12):470-4
pubmed: 26602794
Front Microbiol. 2016 Nov 29;7:1935
pubmed: 27965655
Eur J Clin Microbiol Infect Dis. 2015 Oct;34(10):2131-6
pubmed: 26292935